Pregled bibliografske jedinice broj: 401575
Gorlin Syndrome Patient with Large Deletion in 9q22.32-q22.33 Detected by Quantitative Multiplex Fluorescent PCR
Gorlin Syndrome Patient with Large Deletion in 9q22.32-q22.33 Detected by Quantitative Multiplex Fluorescent PCR // Dermatology (Basel), 219 (2009), 2; 111-118 doi:10.1159/000219247 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 401575 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Gorlin Syndrome Patient with Large Deletion in 9q22.32-q22.33 Detected by Quantitative Multiplex Fluorescent PCR
Autori
Musani, Vesna ; Čretnik, Maja ; Šitum, Mirna ; Basta-Juzbašić, Aleksandra ; Levanat, Sonja
Izvornik
Dermatology (Basel) (1018-8665) 219
(2009), 2;
111-118
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Chromosome deletion ; Gorlin syndrome ; PTCH1 ; Quantitative multiplex fluorescent polymerase chain reaction ; Sequence-tagged sites
Sažetak
Background: Gorlin syndrome is a rare autosomal-dominant disorder characterized by a wide range of developmental abnormalities and various tumors. The syndrome is caused by mutations in PTCH1 , a tumor suppressor gene located at 9q22.32. We describe a Gorlin syndrome case with typical features of the syndrome and no mutations in PTCH1 , but with a large deletion of the 9q22 region that has rarely been described. Objective: To fully haracterize the large deletion in the patient. Methods: In order to map the size and position of the deletion, we developed quantitative multiplex fluorescent PCR with polymorphic markers surrounding the PTCH1 gene, followed by long-range PCR and sequencing. Results: The deleted segment of 4.5 Mb in the 9q22.32-22.33 region was determined, and included the entire PTCH1 , its promoter and 22 OMIM genes. Conclusion: We suggest that screening for large deletions should be included in standard mutation screening for Gorlin syndrome patients.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
POVEZANOST RADA
Projekti:
098-0982464-2461 - Prijenos signala u tumorima: Hh-Gli put, interakcije i potencijalne terapije (Levanat, Sonja, MZOS ) ( CroRIS)
Ustanove:
Institut "Ruđer Bošković", Zagreb,
Medicinski fakultet, Zagreb,
KBC "Sestre Milosrdnice"
Profili:
Aleksandra Basta-Juzbašić
(autor)
Vesna Musani
(autor)
Mirna Šitum
(autor)
Sonja Levanat
(autor)
Maja Sabol
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE